Article
Author(s):
DeepIntent, a healthcare advertising technology company built to influence better patient health and business outcomes, announced it has reached a significant milestone, achieving growth for the fifth consecutive year and a triple-digit percentage growth rate across connected television (CTV) campaigns.
In 2022, DeepIntent experienced triple-digit growth in CTV investment on its demand side platform, making CTV one of the fastest-growing channels for the hundreds of pharmaceutical brands now using the DeepIntent Healthcare Advertising Platform.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.